Dodecyltriphenylphosphonium inhibits multiple drug resistance in the yeast Saccharomyces cerevisiae

Biochem Biophys Res Commun. 2014 Aug 8;450(4):1481-4. doi: 10.1016/j.bbrc.2014.07.017. Epub 2014 Jul 11.

Abstract

Multiple drug resistance pumps are potential drug targets. Here we asked whether the lipophilic cation dodecyltriphenylphosphonium (C12TPP) can interfere with their functioning. First, we found that suppression of ABC transporter gene PDR5 increases the toxicity of C12TPP in yeast. Second, C12TPP appeared to prevent the efflux of rhodamine 6G - a fluorescent substrate of Pdr5p. Moreover, C12TPP increased the cytostatic effects of some other known Pdr5p substrates. The chemical nature of C12TPP suggests that after Pdr5p-driven extrusion the molecules return to the plasma membrane and then into the cytosol, thus effectively competing with other substrates of the pump.

Keywords: Antifungal drugs; Dodecyltriphenylphosphonium; Multiple drug resistance; Pdr5; Yeast.

MeSH terms

  • Drug Resistance, Microbial / drug effects*
  • Drug Resistance, Microbial / genetics
  • Drug Resistance, Multiple / drug effects*
  • Drug Resistance, Multiple / genetics
  • Organophosphorus Compounds / pharmacology*
  • Saccharomyces cerevisiae / drug effects*
  • Saccharomyces cerevisiae / genetics

Substances

  • Organophosphorus Compounds
  • dodecyltriphenylphosphonium